David Farrell, PhD, Adjunct Professor, Department of Medicine, has been elected a Fellow of the American Heart Association (FAHA) affiliated with the Council on Arteriosclerosis, Thrombosis and Vascular Biology during the Annual ATVB Conference.
FAHA Fellowship recognizes excellence in the fields of arteriosclerosis, thrombosis and vascular biology, and leadership/volunteer service to the American Heart Association. Fellowship is open to scientists, and clinical professionals who diagnose and manage patients with arteriosclerosis or thrombotic disease.
Dr. Farrell is a Professor of Medicine in the Division of Cardiovascular Medicine, and has appointments in the Department of Molecular and Medical Genetics and the Department of Physiology and Pharmacology. He is also Founder and Chief Scientific Officer of Gamma Therapeutics, Inc., an Oregon-based early stage biotechnology venture developing a novel class of biopharmaceutical and diagnostic test solutions for the cardiovascular disease industry. He is currently Co-Chair of the Thrombosis 2 Committee of the American Heart Association and on the Editorial Board of the open access journal Thrombosis. His primary research interests are in the biochemistry, genetics, regulation, and epidemiology of the blood clotting factor fibrinogen.